These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37993750)

  • 1. Nucleoporin 93, a new substrate of the E3 ubiquitin protein ligase HECTD1, promotes esophageal squamous cell carcinoma progression.
    Zhang J; Xin Y; Ling X; Liang H; Zhang L; Fang C; Ma J
    Hum Cell; 2024 Jan; 37(1):245-257. PubMed ID: 37993750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 3. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
    Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
    Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas.
    Zhang H; Qin G; Zhang C; Yang H; Liu J; Hu H; Wu P; Liu S; Yang L; Chen X; Zhao X; Wang L; Zhang Y
    J Exp Clin Cancer Res; 2021 Jun; 40(1):209. PubMed ID: 34167551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells.
    Yue Y; Lian J; Wang T; Luo C; Yuan Y; Qin G; Zhang B; Zhang Y
    Cancer Sci; 2020 Mar; 111(3):795-806. PubMed ID: 31883400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
    Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
    Zheng L; Zhao Z; Rong L; Xue L; Song Y
    J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
    Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
    Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA Repair Protein Rad51 Induces Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma via a p38/Akt-Dependent Pathway.
    Chiu WC; Fang PT; Lee YC; Wang YY; Su YH; Hu SC; Chen YK; Tsui YT; Kao YH; Huang MY; Yuan SF
    Ann Surg Oncol; 2020 Jun; 27(6):2090-2101. PubMed ID: 31749080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WISP3 suppresses ESCC progression by inhibiting the IGF-2-IGF1R-AKT signaling cascade.
    Yu X; Mao R; Feng W; Zhao Y; Qin J; Yang Y; Wang A; Shi Z
    Exp Cell Res; 2021 Dec; 409(1):112871. PubMed ID: 34672999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
    Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
    J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma.
    Hu J; Dai C; Ding Z; Pan Y; Lu L; Bao J; Zheng J
    BMC Cancer; 2024 Jun; 24(1):759. PubMed ID: 38914958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway.
    Liu R; Lu Y; Li J; Yao W; Wu J; Chen X; Huang L; Nan D; Zhang Y; Chen W; Wang Y; Jia Y; Tang J; Liang X; Zhang H
    Cell Death Dis; 2024 Apr; 15(4):291. PubMed ID: 38658569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MIR503HG promotes esophageal squamous cell carcinoma cell proliferation, invasion and migration via hsa-miR-503 pathway].
    Gong TY; Chen HY; Liu ZH
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1160-1167. PubMed ID: 36380664
    [No Abstract]   [Full Text] [Related]  

  • 17. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
    Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
    Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
    Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X
    Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
    J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
    Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
    Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.